Catalysts for $AMGN
166 tracked
Aug 21, 2003
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jul 24, 2003
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jul 24, 2003
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jul 24, 2003
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jun 5, 2003
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Sep 12, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Sep 12, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Aug 30, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jan 15, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jan 15, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jan 15, 2002
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jun 15, 2001
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Jun 6, 2000
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
May 27, 1999
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
Nov 2, 1998
approval
ENBREL (ETANERCEPT) — FDA approval
AMGEN INC
→
RECRUITING
phase readout
NCT07321626: Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
AMGEN INC
→